Condition
USCOM
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Uscom
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Uscom2
- Echocardiography1
Active Sponsors
- Icahn School of Medicine at Mount Sinai1
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital1
Top Investigators
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Related Conditions
- Echocardiography1
- Fetal Growth Restriction1
- Echocardiography Guided Fluid Management1